Month: April 2024

NEW YORK and TOKYO, April 01, 2024 (GLOBE NEWSWIRE) — HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or the “Company”), a leading enterprise software and consulting services company based in Tokyo, announced that it has authorized a dividend payment in the amount of $0.02 per share of Common Stock, resulting in an aggregate $417,283 in total dividends to be paid by the Company. After evaluating the Company’s balance sheet and financial profile, HeartCore and its Board of Directors deemed it was in the best interest of the Company and stockholders to declare and authorize a dividend on the common stock. The record date for holders of the Common Stock to participate in the dividend is April 26, 2024, and the payment date will be May 3, 2024. HeartCore may issue quarterly dividends going forward, contingent upon the financial...

Completion of Sale to an Affiliate of H.I.G. Capital for $375 Million Establishes Pure-Play Dental Business PALM BEACH GARDENS, Fla., April 01, 2024 (GLOBE NEWSWIRE) — ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that it has closed the previously communicated sale of its Spine business to an affiliate of H.I.G. Capital for $375 million in total consideration, including $315 million in cash and a $60 million promissory note. “The completion of the sale of our Spine business is the culmination of months of partnership with H.I.G. Capital and years of commitment from our global Spine team members; I would like to thank everyone for their immense contributions,” said Vafa Jamali, President and Chief Executive Officer. “I could not be more excited for the future of our company as we...

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Vancouver, British Columbia, April 01, 2024 (GLOBE NEWSWIRE) — MegaWatt Lithium and Battery Metals Corp. (CSE:MEGA) (FSE: WR20) (OTCQB: WALRF) (the “Company” or “MegaWatt“) announces, it has entered into a share exchange agreement dated effective April 1, 2024 (the “Share Exchange Agreement”) among the Company, Labrador Mineral Resources Inc. (“Labrador”), a private company existing under the laws of British Columbia, and the shareholders of Labrador (the “Shareholders”), pursuant to which, subject to regulatory approval, the Company will acquire all of the issued and outstanding shares of Labrador (the “Proposed Transaction”). Labrador purchased a 100% interest (subject only to a 1.5% NSR) in the Benedict Mountains...

– Announced private placement of up to $149.4 million led by RA Capital Management with participation from Armistice Capital, Special Situations Funds and Soleus Capital; pro forma cash and cash equivalents from upfront proceeds expected to provide runway through the end of 2025 – CervoMed on track to complete enrollment in 2Q 2024 in its RewinD-LB Phase 2b clinical trial evaluating neflamapimod in patients with dementia with Lewy bodies (DLB); topline data expected in 4Q 2024 – Integrated summary of results from AscenD-LB Phase 2a trial published in peer-reviewed journal and presentations at a major scientific conference further inform on the potential of neflamapimod in DLB and probability of success in RewinD-LB – Appointed Joshua Boger, Ph.D., as Chair of the Board of Directors; Dr. Boger is the founder and...

CUPERTINO, CA, April 01, 2024 (GLOBE NEWSWIRE) — via NewMediaWire — Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company focused on low and negative carbon intensity products, today announced the design, installation and implementation of the Microsoft DynamicsTM enterprise resource planning (ERP) system worldwide for all Aemetis operations in the U.S. and India to support current operations and expansion projects.  The tools and processes required to operate a global company, including manufacturing, supply chain, finance and accounting, are included in the Microsoft DynamicsTM ERP system. The Microsoft DynamicsTM ERP system is designed to manage medium to large corporations and was selected specifically to provide a world-class platform for the Aemetis Biogas dairy renewable natural gas business,...

BOSTON, April 01, 2024 (GLOBE NEWSWIRE) — X4 Pharmaceuticals (Nasdaq: XFOR), a company driven to improve the lives of people with rare diseases of the immune system, today announced that management will be participating in the upcoming Needham 23rd Annual Healthcare Conference being held virtually from April 8-11, 2024, and the Piper Sandler Spring Biopharma Symposium being held in Boston from April 16-17, 2024. Needham 23rd Annual Healthcare Conference  Date: Monday, April 8, 2024  Time: 9:30 AM ET  Format: Corporate Presentation  Webcast Link   Piper Sandler Spring Biopharma Symposium  Date: Wednesday, April 17, 2024  Format: 1×1 Meetings   About X4 Pharmaceuticals X4 Pharmaceuticals is a late-stage clinical biopharmaceutical company driven to improve the lives of people with rare diseases...

Moving corporate office from Austell, of over 40 years at this location, to KennesawPlateau Excavation, the largest sitework contractor in the SoutheastHyundai SK Battery Jobsite – Won Georgia Deal of the Year in 2023. This job alone is bringing 3500 new jobs to Bartow County.Kennesaw, GA, April 01, 2024 (GLOBE NEWSWIRE) — Plateau Excavation, the largest sitework contractor in the Southeast, founded in 1983, is pleased to announce the relocation of its corporate headquarters from Austell, GA, to Kennesaw, GA.  Plateau Excavation began its journey with leased machines and small jobs, seizing opportunities amidst the banking industry crisis of the early 80s. Recognizing the rapid growth of the Atlanta area, founder Greg Rogers dove headfirst into excavation, starting with grading streets in budding subdivisions and...